FEATURE ARTICLES
Outsourcing adds capacity and specialized knowledge to your supply chain. But contractors come in several types. Here's how to pick the right one.
- 100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing
- 3 [Potential] Solutions To A More Resilient Supply Chain
- September 2025 — CDMO Opportunities And Threats Report
- Extreme Weather Is Testing Pharma's Resilience — Is It Ready?
- Risk-Based Analytical Method Selection In Cleaning Validation Using ASTM International Standards
- Eco-Friendly HBL: Cheaper, Cleaner, And Ready For Pharma
- Import Product Specifications And Drug Registration Testing For China
PHARMA ONLINE WHITE PAPERS
-
![Human lungs healthcare-GettyImages-1388994501]( "Developing Pulmonary Dosage Forms For Complex Molecule Delivery")
Developing Pulmonary Dosage Forms For Complex Molecule DeliveryDiscover how next-generation inhalation technologies can transform pulmonary drug delivery and unlock new therapeutic possibilities for a wide range of respiratory diseases.
-
Next Generation Sequencing In Viral Safety Testing7/25/2025
Next Generation Sequencing (NGS) offers a sensitive, high-throughput solution for detecting adventitious viral agents (AVAs), improving biopharmaceutical safety and accelerating regulatory-compliant product development.
-
Normalized Data In Microbial Continuous Monitoring7/24/2025
Learn how EU GMP Annex 1 (2022) redefines cleanroom air monitoring standards and emphasizes continuous viable sampling in Grade A and B environments to ensure aseptic integrity and compliance.
-
Preclinical Evaluation Of RSV Vaccines And Antivirals In BALB/c Mice6/10/2025
Accelerate your RSV therapeutic development with clinically relevant preclinical models and expert IND-enabling services that deliver the data needed to advance confidently toward clinical trials.
-
Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs8/27/2024
Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.
-
Mitigating Early Development Risks9/11/2024
Discover how the efficient screening of biologic candidates accelerates the discovery process, reduces costs, and improves the likelihood of commercializing safe and effective drugs.
PHARMA ONLINE APP NOTES & CASE STUDIES
NEWSLETTER ARCHIVE
- 10.30.25 -- Innovation Spotlight: Smarter, Faster, More Flexible Bioprocessing
- 10.30.25 -- The Regulatory Imperative To Improve Environmental And Sustainability Stewardship In Biopharma
- 10.30.25 -- STREAM Edition: Microbial Expression Versus Chemical Synthesis In Peptide Production
- 10.29.25 -- Consistent OOF Delivery Performance That Defines Manufacturing Reliability
- 10.29.25 -- Looking to outsource pDNA or mRNA process development?
INDUSTRY NEWS
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
-
![Dollar Icon from Medical pills-GettyImages-1708867150]( "Oregon Court Upholds Drug Price Transparency Law")
Oregon Court Upholds Drug Price Transparency LawThe law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Eli Lilly Announces $1.2 Billion Investment To Expand Puerto Rico Manufacturing Site For Next-Gen Oral Medicines10/30/2025
Eli Lilly and Company (NYSE: LLY) announced today a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico. This new investment will integrate advanced technologies and expand production capacity within the existing campus to support the company's growing portfolio of oral solid medicines in cardiometabolic health, neuroscience, oncology and immunology.
-
Apeloa Successfully Passes 20th FDA Inspection With No Action Indicated10/30/2025
Following a rigorous and comprehensive evaluation process, Apeloa Pharmaceutical has successfully passed its 20th US FDA inspection, a top achievement in the industry that underscores Apeloa’s exemplary quality and management standards.
-
Tema Sinergie Acquires Majority Stake In Aseptic Filling OEM 6Bio10/29/2025
TEMA Sinergie S.p.A., a global leader in isolation systems for the Radiopharma and Biotech Pharma industries, today announced the acquisition of a majority stake in 6Bio, a Spanish company specialized in high-performance aseptic filling technology.
-
Serán Bioscience Expands Commercial Manufacturing With New 100,000 Sq. Ft. Campus In Bend, Oregon10/29/2025
Serán BioScience, LLC, a leading science-driven drug development partner, today announced the completion of two of the three new buildings and commencement of construction of the third facility for of its new 100,000 ft2 commercial manufacturing campus in Bend, Oregon. The new campus will encompass a 50,000 ft2 manufacturing facility, complemented by an adjacent 50,000 ft2 space dedicated to specialized packaging and supply chain operations. The expansion marks a significant milestone in Serán’s mission to provide fully integrated support from first-in-human (FiH) trials through commercial-scale production of small-molecule therapeutics.
-
Owen Mumford Launches EcoSafe® Safety Syringe Platform – Smarter For Budgets And Kinder To The Planet10/29/2025
Oxford - Medical device expert Owen Mumford has extended its 1ml safety syringe platform by adding a companion reusable autoinjector.
